Intravenous hydration according to current guidelines in the prevention of contrast induced nephropathy-the AMACING trial
- PMID: 28840037
- PMCID: PMC5542972
- DOI: 10.21037/jtd.2017.06.80
Intravenous hydration according to current guidelines in the prevention of contrast induced nephropathy-the AMACING trial
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
No prophylaxis is non-inferior and cost-saving to prophylactic intravenous hydration in preventing contrast-induced nephropathy on requiring iodinated contrast material administration.J Thorac Dis. 2017 Jun;9(6):1440-1442. doi: 10.21037/jtd.2017.05.59. J Thorac Dis. 2017. PMID: 28740652 Free PMC article. No abstract available.
-
Diagnosing and treating contrast-induced acute kidney injury in 2017.J Thorac Dis. 2017 Jun;9(6):1443-1445. doi: 10.21037/jtd.2017.05.58. J Thorac Dis. 2017. PMID: 28740653 Free PMC article. No abstract available.
References
-
- Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 2017;389:1312-22. 10.1016/S0140-6736(17)30057-0 - DOI - PubMed
-
- Veligheids Management Systeem. VMS veiligheidsprogramma: voorkomen van nierinsufficiëntie bij intravasculair gebruik van jodiumhoudende contrastmiddelen. September, 2009. Accessed May 17, 2017. Available online: http://www.vmszorg.nl/themas/nierinsufficientie
-
- Mandrola J. Commentary: Contrast-Induced Nephropathy: Signal or Noise? Medscape. March 07, 2017. Accessed May 17, 2017. Available online: http://www.medscape.com/viewarticle/876852
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources